1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Pharmaceutical Analysis & Statistics, February 2017

Pharmaceutical Analysis & Statistics, February 2017

24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

All regions

1-30 of about 23000 reports

Purchase Reports From Reputable Market Research Publishers

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

  • Industries : Therapy
2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

  • Industries : Therapy
2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

  • Industries : Therapy
2017 Europe Immunodiagnostics Market: Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 Europe Immunodiagnostics Market: Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 37500
  • Industry report
  • February 2017
  • by Venture Planning Group

This new 31-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test. This report provides a granular strategic analysis of over 100 clinical chemistry, ...

  • Industries : Therapy
2017 Europe Clinical Chemistry Market: Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 Europe Clinical Chemistry Market: Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 37500
  • Industry report
  • February 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both centralized ...

  • Industries : Therapy
2017 Europe Tumor Marker Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 Europe Tumor Marker Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 36000
  • Industry report
  • February 2017
  • by Venture Planning Group

This new 31-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as well as ...

  • Industries : Therapy
2017-2021 World Clinical Chemistry and Immunodiagnostic Markets: Global Opportunities and Growth Strategies for Instrument and Reagent Suppliers

2017-2021 World Clinical Chemistry and Immunodiagnostic Markets: Global Opportunities and Growth Strategies for Instrument and Reagent Suppliers

  • $ 23500
  • Industry report
  • February 2017
  • by Venture Planning Group

Complete report $37,500.  DataPack (test volumes, sales forecasts, supplier shares) $23,500.VPGMarketReserch.com's new report is a seven-country strategic analysis of major business opportunities emerging ...

  • Industries : Therapy, In Vitro Diagnostics
Immunodiagnostics Market 2017-2021: US, Europe, Japan--Opportunities for Instrument and Reagent Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review

Immunodiagnostics Market 2017-2021: US, Europe, Japan--Opportunities for Instrument and Reagent Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review

  • $ 23500
  • Industry report
  • December 2016
  • by Venture Planning Group

Complete report PDF $37,500, DataPack (500 tables) $23,500. The report is available by geographic region, country, section, market segment, test category, and individual assay. VPGMarketResearch.com's ...

  • Industries : Therapy
2017 Asia-Pacific Immunodiagnostics Market: Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 Asia-Pacific Immunodiagnostics Market: Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 16500
  • Industry report
  • February 2017
  • by Venture Planning Group

This new 17-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test. This report provides a granular strategic analysis of over 100 clinical chemistry, ...

  • Industries : Therapy
2017 Asia-Pacific Clinical Chemistry Market: Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 Asia-Pacific Clinical Chemistry Market: Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 16500
  • Industry report
  • February 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both centralized ...

  • Industries : Therapy
2017-2021 Europe Clinical Chemistry and Immunodiagnostic Markets: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

2017-2021 Europe Clinical Chemistry and Immunodiagnostic Markets: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

  • $ 12800
  • Industry report
  • February 2017
  • by Venture Planning Group

Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800VPGMarketResearch.com's new five-country report is a strategic analysis of major business opportunities emerging ...

  • Industries : Therapy, In Vitro Diagnostics
2017-2021 Europe Tumor Markers: France, Germany, Italy, Spain, UK--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

2017-2021 Europe Tumor Markers: France, Germany, Italy, Spain, UK--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

  • $ 12800
  • Industry report
  • January 2017
  • by Venture Planning Group

Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800. Summary This comprehensive five-country report contains 820 pages, 320 tables, and presents analysis of the ...

  • Industries : Therapy
2017-2021 Europe Clinical Chemistry and Immunodiagnostics Markets: France, Germany, Italy, Spain, UK--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

2017-2021 Europe Clinical Chemistry and Immunodiagnostics Markets: France, Germany, Italy, Spain, UK--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

  • $ 12800
  • Industry report
  • December 2016
  • by Venture Planning Group

Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800. This new report is a five-country strategic analysis of major business opportunities emerging in the clinical ...

  • Industries : Therapy
Europe Immunodiagnostics Market 2017-2021: France, Germany, Italy, Spain, UK--Opportunities for Instrument and Reagent Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review

Europe Immunodiagnostics Market 2017-2021: France, Germany, Italy, Spain, UK--Opportunities for Instrument and Reagent Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review

  • $ 12800
  • Industry report
  • December 2016
  • by Venture Planning Group

Complete report $19,700 DataPack (test volumes, sales forecasts, supplier shares) $12,800. This comprehensive five-country report contains 900 pages and 335 tables. The report explores future trends in ...

  • Industries : Therapy
Europe Cancer Diagnostics Market 2017-2021:  France, Germany, Italy, Spain, UK--Opportunities for Instrument and Reagent Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies

Europe Cancer Diagnostics Market 2017-2021: France, Germany, Italy, Spain, UK--Opportunities for Instrument and Reagent Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies

  • $ 12800
  • Industry report
  • December 2016
  • by Venture Planning Group

Complete report $19,700.DataPack (test volumes, sales forecasts, supplier shares) $12,800. Summary This comprehensive five-country report contains 820 pages, 320 tables, and presents analysis of the majo ...

  • Industries : Therapy
PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025 Summary Psoriatic arthritis (PsA) is a chronic immune-mediated arthritis typically affecting the large joints, especially ...

  • Industries : Pathology, Pharmaceutical
  • Countries : Japan, World, United States, Asia
Global Animal Feed Additives Market, Mordor Intelligence LLP

Global Animal Feed Additives Market, Mordor Intelligence LLP

  • $ 9500
  • Industry report
  • December 2016
  • by Mordor Intelligence LLP

The Global Animal Feed Additives market is projected to cross USD 37 billion by 2021 from USD 28.6 billion in 2016, growing at a CAGR of 5.34% over the forecast period. Feed additives are essential in ...

  • Industries : Livestock, OTC
  • Countries : World, Europe, United States
2017-2021 US Clinical Chemistry and Immunodiagnostic Markets: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

2017-2021 US Clinical Chemistry and Immunodiagnostic Markets: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

  • $ 7500
  • Industry report
  • February 2017
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7,500. VPGMarketResearch.com's new report is a strategic analysis of major business opportunities emerging in the US ...

  • Industries : Therapy
US Immunodiagnostics Market 2017-2021: Opportunities for Instrument and Reagent Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review

US Immunodiagnostics Market 2017-2021: Opportunities for Instrument and Reagent Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review

  • $ 7500
  • Industry report
  • December 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7,500. VPGMarketResearch.com's new report is a strategic analysis of major business opportunities emerging in the US ...

  • Industries : Therapy
  • Countries : United States
2017 Latin America Immunodiagnostics Market: Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Competitive Strategies, Instrumentation Review, Opportunities

2017 Latin America Immunodiagnostics Market: Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Competitive Strategies, Instrumentation Review, Opportunities

  • $ 7400
  • Industry report
  • February 2017
  • by Venture Planning Group

This new 7-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test. Rationale Clinical chemistry and immunodiagnostic markets are undergoing significant ...

  • Industries : Therapy
2017 Latin America Clinical Chemistry Market: Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Competitive Strategies, Instrumentation Review,  Opportunities

2017 Latin America Clinical Chemistry Market: Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Competitive Strategies, Instrumentation Review, Opportunities

  • $ 7400
  • Industry report
  • February 2017
  • by Venture Planning Group

Rationale Clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system ...

  • Industries : Therapy
Frontier Pharma: Melanoma Therapeutics - Cytokine and Multiple Targeted Small Molecules and mAbs Dominate Pipeline and First-in-Class Innovation

Frontier Pharma: Melanoma Therapeutics - Cytokine and Multiple Targeted Small Molecules and mAbs Dominate Pipeline and First-in-Class Innovation

  • $ 6995
  • Industry report
  • January 2017
  • by GBI Research

Frontier Pharma: Melanoma Therapeutics - Cytokine and Multiple Targeted Small Molecules and mAbs Dominate Pipeline and First-in-Class Innovation Summary Melanoma is a type of cancer that begins in the ...

  • Industries : Therapy, Pharmaceutical
  • Countries : World
Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations

Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations

  • $ 6995
  • Industry report
  • December 2016
  • by GBI Research

Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations Summary Hepatitis C is a blood-borne viral infection ...

  • Industries : Pathology, Healthcare
  • Countries : World
Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects

Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects

  • $ 6995
  • Industry report
  • December 2016
  • by GBI Research

Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects Summary Type 2 diabetes ...

  • Industries : Pathology, Chronic Disease, Therapy
  • Countries : World
Global Markets for Animal Therapeutics and Diagnostics

Global Markets for Animal Therapeutics and Diagnostics

  • $ 6650
  • Industry report
  • February 2017
  • by BCC Research

Use this report to: - Analyze market segments, namely vaccines, pharmaceuticals, feed additives and diagnostics - Receive information about product categories, use of products, forecasts and competitive ...

  • Industries : OTC
  • Countries : World
Breakthrough Therapies: Market Dynamics and Investment Opportunities

Breakthrough Therapies: Market Dynamics and Investment Opportunities

  • $ 6650
  • Industry report
  • January 2017
  • by BCC Research

Use this report to: - Analyze the challenges and opportunities of developing breakthrough therapies, compare difference fast track drug development approaches and the potential risk and rewards of gaining ...

  • Industries : Therapy, Pathology
  • Countries : World
Global Programmed Death-1 & Programmed Death Ligand-1 Inhibitors Pipeline Analysis, Market Size, Share, Development, Growth and Demand Forecast to 2025 - Industry Insights by Drug, by Mechanism of Action

Global Programmed Death-1 & Programmed Death Ligand-1 Inhibitors Pipeline Analysis, Market Size, Share, Development, Growth and Demand Forecast to 2025 - Industry Insights by Drug, by Mechanism of Action

  • $ 6500
  • Industry report
  • January 2017
  • by P&S Market Research

Programmed Death-1 (PD-1) and Programmed Death Ligand-1 (PD-L1) inhibitors are the therapeutic candidates or drugs, popularly known as checkpoint inhibitors, used most commonly for the treatment of cance ...

  • Industries : Therapy, Pathology
  • Countries : United Kingdom, United States, World
United Kingdom Diabetes Care Devices Market Outlook to 2022 - Glucose Monitoring and Insulin Delivery

United Kingdom Diabetes Care Devices Market Outlook to 2022 - Glucose Monitoring and Insulin Delivery

  • $ 5995
  • Industry report
  • January 2017
  • by GlobalData

United Kingdom Diabetes Care Devices Market Outlook to 2022 - Glucose Monitoring and Insulin Delivery Summary GlobalData’s new report, "United Kingdom Diabetes Care Devices Market Outlook to 2022", provides ...

  • Industries : Medical Device, Healthcare
  • Countries : United Kingdom, Europe
EU5 Insulin Delivery Market Outlook to 2022

EU5 Insulin Delivery Market Outlook to 2022

  • $ 5995
  • Industry report
  • January 2017
  • by GlobalData

EU5 Insulin Delivery Market Outlook to 2022 Summary GlobalData’s new report, "EU5 Insulin Delivery Market Outlook to 2022", provides key market data on the EU5 Insulin Delivery market. The report provides ...

  • Industries : Medical Device, Healthcare
  • Countries : Europe
China Diabetes Care Devices Market Outlook to 2022 - Glucose Monitoring and Insulin Delivery

China Diabetes Care Devices Market Outlook to 2022 - Glucose Monitoring and Insulin Delivery

  • $ 5995
  • Industry report
  • January 2017
  • by GlobalData

China Diabetes Care Devices Market Outlook to 2022 - Glucose Monitoring and Insulin Delivery Summary GlobalData’s new report, "China Diabetes Care Devices Market Outlook to 2022", provides key market ...

  • Industries : Medical Device
  • Countries : China, Asia

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.